We are pleased to announce that Journal of Laboratory and Precision Medicine (JLPM) has obtained its latest impact factor for the 2025 citation year: 1.8 (Figure 1).
Figure 1 Journal Impact Factor of JLPM
Journal of Laboratory and Precision Medicine (JLPM, J Lab Precis Med, Online ISSN: 2519-9005) is published by AME Publishing Company, with support from Wolters Kluwer (the journal content will be made available on Wolters Kluwer Health’s Lippincott and Ovid platforms). It is an open access, peer-reviewed, international online journal that publishes both solicited and unsolicited manuscripts. With the aim of reporting new findings, JLPM provides current, practical information from the laboratory and precision medicine field. It publishes original articles, editorials, case reports, and reviews covering all aspects of laboratory medicine.
The announcement of the journal’s latest impact factor is a significant achievement for the journal, allowing us to further develop the journal into a high-impact respected source of information with international reach. We would like to extend our heartfelt gratitude to all our editorial team members, guest editors, authors, and reviewers for their significant contributions.
We look forward to the continuous cooperation with all the individuals mentioned above and those who are interested in laboratory medicine to bring more exciting content to readers in the coming future.
2025 Journal Impact Factors of AME journals
We are also pleased to share the latest impact factors of all journals published under AME Publishing Company (Table 1).
- 37 AME journals received a Journal Impact Factor (JIF) this year, with three journals receiving their first JIF
- 12 journals have one or more categories ranked in Q1 or Q2
These achievements reflect the continuous growth and academic influence of our journal portfolio. We sincerely thank all contributors across our journals for their dedication and support.
Table 1 2025 Journal Impact Factors of AME journals
Editorial Office
Journal of Laboratory and Precision Medicine